Bioxcel Therapeutics, INC. (BTAI) SEC Filings — 2024
31 SEC filings for Bioxcel Therapeutics, INC. (BTAI) in 2024.
Filings
- BioXcel Therapeutics Files Definitive Proxy Statement — DEF 14A · Dec 30, 2024
- BioXcel Therapeutics Enters Material Definitive Agreement — 8-K · Nov 25, 2024
- BioXcel Therapeutics Files 8-K: Agreements, Equity Sales, Officer Changes — 8-K · Nov 21, 2024
- BioXcel Therapeutics Files 8-K for Financials — 8-K · Nov 14, 2024
- BioXcel Therapeutics Q3 2024 Update: Cash Position and Offerings — 10-Q · Nov 14, 2024
- BioXcel Therapeutics Appoints New CMO, Director — 8-K · Oct 9, 2024
- BioXcel Therapeutics Faces Delisting Notice — 8-K · Sep 20, 2024
- BioXcel Therapeutics: CMO Departs, New Directors Appointed — 8-K · Sep 19, 2024
- Bioxcel Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Sep 10, 2024
- BioXcel Therapeutics to be Acquired by Kindred Biosciences Affiliate — 8-K · Sep 9, 2024
- BioXcel Therapeutics to be Acquired for $1.1 Billion — 8-K · Sep 5, 2024
- BioXcel Therapeutics Files 8-K on Financials — 8-K · Aug 6, 2024
- BioXcel Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 6, 2024
- BioXcel Therapeutics Enters Material Definitive Agreement — 8-K · Jul 17, 2024
- BioXcel Therapeutics Files 8-K — 8-K · Jul 16, 2024
- BioXcel Sells Neuroscience Drug Candidate to Sun Pharma for $10M — 8-K · Jun 25, 2024
- BioXcel Therapeutics Files 8-K on Corporate Changes — 8-K · Jun 12, 2024
- BioXcel Holdings & Vimal Mehta Amend 13D Filing — SC 13D/A · Jun 6, 2024
- BioXcel Therapeutics Files 8-K on Financials — 8-K · May 9, 2024
- BioXcel Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- BioXcel Therapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 29, 2024
- BioXcel Therapeutics Files 8-K — 8-K · Apr 22, 2024
- BioXcel Therapeutics to be Acquired for $1.00/Share — 8-K · Apr 10, 2024
- BioXcel Therapeutics Files 8-K — 8-K · Mar 25, 2024
- BioXcel Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 22, 2024
- BioXcel Therapeutics Files 8-K on Financials — 8-K · Mar 12, 2024
- BioXcel Therapeutics Files 8-K for Regulation FD Disclosure — 8-K · Feb 14, 2024
- BioXcel Therapeutics Files 8-K on Material Definitive Agreement — 8-K · Feb 12, 2024
- FMR LLC & Abigail Johnson Disclose 8.6% Stake in BioXcel Therapeutics — SC 13G/A · Feb 9, 2024
- BioXcel Therapeutics Files 8-K for Other Events on Feb 7, 2024 — 8-K · Feb 8, 2024
- Adage Capital Partners Cuts BioXcel Therapeutics Stake to 1.1% — SC 13G/A · Feb 7, 2024